← Leaderboards
Ilya Ilin
General Biophysics, Llc
$2,081,549
Attributed
$3,763,098
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,763,098 · 3
By mechanism
R42$2,550,000 · 1
R41$1,213,098 · 2
Top collaborators
- Howard L Weiner3 shared
- Oleg Butovsky2 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposSignal TransductionTherapeutically EffectiveImmuneNeuroprotective AgentsGasesInhalationXenonMouse ModelNerve DegenerationCellsAnestheticsBrainBrain InjuriesPhenotypeGenetic Risk FactorPathogenicityMolecular ProfilingApp-Ps1Disease ProgressionDoseBiologyClinical TrialsAcute
Grant awards (6)
Xenon gas inhalation as a novel treatment for opioid withdrawal syndrome$400,000
R41 · FY2025 · DA · contact PI
Phase 1 Trial to Assess Safety and Immune Effects of Xenon Gas in HealthyHuman Subjects$50,000
R42 · FY2025 · AG · contact PI
Phase 1 Trial to Assess Safety and Immune Effects of Xenon Gas in Healthy Human Subjects$1,181,555
R42 · FY2024 · AG · contact PI
Phase 1 Trial to Assess Safety and Immune Effects of Xenon Gas in Healthy Human Subjects$1,318,445
R42 · FY2023 · AG · contact PI
Xenon gas treatment to modulate microglia in neurodegenerative diseases$313,552
R41 · FY2022 · AG · contact PI
Xenon gas treatment to modulate microglia in neurodegenerative diseases$499,546
R41 · FY2021 · AG · contact PI